Serving hundreds of leading biopharmaceutical companies globally:

US Army
Cipla
Chubb
QuintilesIMS
McKinsey
Cantor Fitzgerald

Make Better Decisions, Faster

Do you need a custom analysis, patent litigation support, or due diligence assistance? Contact Us

Short-term or Annual Plans • Discounts for Multiple Users/Years • Upgrade Anytime

82% Pick This

Pharmaceutical Drugs

$8,000/year

  • US & International Patents
  • Active and Expired Patents in 134 Countries, Regulatory Protections and Exclusivities
  • Anticipate Generic Entry
  • Loss-of-Exclusivity Dates, Paragraph IV Challenges, Tentative Approvals, Authorized Generics, and more…
  • Find Commercial Opportunities
  • Single Source Off-Patent Drugs, Search Patents by Dosage Form / Therapeutic Class
  • Drug Sourcing
  • API Vendors, Finished Product Suppliers, First Generic Entrants

 

Biologic Drugs

$3,000/year

  • US & International Patents
  • Active and Expired Patents in 134 Countries
  • Finished Product Suppliers
  • Manufacturers

 

Drugs In Development

$6,000/year

  • Drug Candidates in Phase I-III Clinical Trials
  • US & International Patents
  • Active and Expired Patents in 134 Countries
  • Clinical Trials
  • API Vendors

US Drug Patent Litigation

$6,000/year

  • US District Court Cases
  • Patent Infringement, Contract Disputes, Antitrust, etc.
  • Patent Trial and Appeal Board
  • PTAB inter partes review, post-grant review

US Drug Prices

$4,000/year

  • Brand vs. Generic Drug Price Gap
  • Find generic entry opportunities
  • Average Pharmacy Cost
  • Set reasonable launch prices
  • Best-Available Price
  • See price ranges

US Top Drug Sales

$3,000/year

  • Annual Gross Revenues & Units Sold
  • Prescription Payment Methods
  • Self-Paid, Private Insurance, Medicaid, etc.
  • Pharmacy Locations & Types
  • Mail-order, Drugstore, in-Clinic, etc.

82% Pick This

Pharmaceutical Drugs

$1,000/monthly

  • US & International Patents
  • Active and Expired Patents in 134 Countries, Regulatory Protections and Exclusivities
  • Anticipate Generic Entry
  • Loss-of-Exclusivity Dates, Paragraph IV Challenges, Tentative Approvals, Authorized Generics, and more…
  • Find Commercial Opportunities
  • Single Source Off-Patent Drugs, Search Patents by Dosage Form / Therapeutic Class
  • Drug Sourcing
  • API Vendors, Finished Product Suppliers, First Generic Entrants

 

Biologic Drugs

$400/monthly

  • US & International Patents
  • Active and Expired Patents in 134 Countries
  • Finished Product Suppliers
  • Manufacturers

 

Drugs In Development

$750/monthly

  • Drug Candidates in Phase I-III Clinical Trials
  • US & International Patents
  • Active and Expired Patents in 134 Countries
  • Clinical Trials
  • API Vendors

US Drug Patent Litigation

$750/monthly

  • US District Court Cases
  • Patent Infringement, Contract Disputes, Antitrust, etc.
  • Patent Trial and Appeal Board
  • PTAB inter partes review, post-grant review

US Drug Prices

$500/monthly

  • Brand vs. Generic Drug Price Gap
  • Find generic entry opportunities
  • Average Pharmacy Cost
  • Set reasonable launch prices
  • Best-Available Price
  • See price ranges

US Top Drug Sales

$400/monthly

  • Annual Gross Revenues & Units Sold
  • Prescription Payment Methods
  • Self-Paid, Private Insurance, Medicaid, etc.
  • Pharmacy Locations & Types
  • Mail-order, Drugstore, in-Clinic, etc.

DrugPatentWatch cited by CNN, NEJM, Nature Journals, and more …

Clients in 66 Countries

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.